NEQCA Accountable Care, Inc is NEQCA’s network-wide Medicare Accountable Care Organization (ACO).  An ACO is a group of providers who voluntarily agree to be accountable for the quality and cost of care of a defined group of Medicare fee-for-service benficiaries. NEQCA’s Medicare ACO is one of 89 new ACOs selected to participate in the Medicare Shared Savings Program, starting January 1, 2015. The Medicare Shared Savings Program is a value-based payment program whose aim is to support better coordination of care for individuals, better health for populations and lower health care costs through continuous quality improvement.

For general questions or additional information about Accountable Care Organizations, please visit www.medicare.gov/acos.html or call 1-800-MEDICARE (1-800-633-4227) TTY users should call 1-877-486-2048. 

If you are a NEQCA provider, and your practice is interested in participating in the ACO, please contact Chantal Buchanan, ACO Director of Operations.

ACO Name and Location

ACO Primary Contact

NEQCA Accountable Care, Inc

325 Wood Road, Suite 210

Braintree, MA 02184

Chantal Z. Buchanan, ACO Director of Operations

cbuchanan@neqca.org

781-356-3336


Organizational Information

ACO Participants 

Abraham P. Dietz, MD

Zanjabee Integrative Medicine and Primary Care

Bickford Health Associates, PC

Wynne Huang, MD

Osterville Healthcare

Plymouth-Carver Primary Care, PC

Theodor T. Herwig, MD, PC

Sergio M. Camargo, MD

William Wittman, MD, PC

Halward Blegen, MD

Timothy Biliouris, MD

Raafat I. Attia Hanna, MD, PC

Robert R. Moore, MD, PhD, PC

South Shore Nephrology, PC

Zouhdi Hajjaj, MD, PC

Tharwat Mikhael Hanna, MD

Pleasant Lake Medical Associates

Resnik Medical Associates

Ali Emami, MD

Christopher E. Coakley, MD

Blue Hills Medical Associates

Katherine Murray Leisure, MD

Shaheen Mian, MD, PC

Eric Johnson, MD, PC

William E. Cobb, MD, PC

Mayflower Medical Associates, PC

Saraswathi Muppana, MD

David Schroeder, MD

Austin J. O'Brien, MD, PC

Renee Remily, MD

Cardiology Associates of Greater Lowell, Inc.

James W. Todd, MD

George P. Meltsakos, MD, PC

Stephen W. Louie, MD

Global Care Medical Group, PC

Tufts Medical Center Community Care 

Greater Lowell Family Practice, PC

Dhirendra S. Bana, MD, PC

Lowell Family Medical Care, PC

Eng Kwa, MD

Mark Romanowsky, MD, PC

Ottavio Nardone, MD

Nephrology Associates of the Merrimack Valley, PC

Yun K. Lam, MD, PC

Philip J. Tavano, MD, PC

Pratt Medical Group, Inc.

Philip S. Kotsios, MD, PC

Maria Gorbovitsky, MD, PC

Sivaram K. Yamajala, MD

North Reading Internal Medicine, PC

Tewksbury Medical Group, PC

John D. Murdock, MD

Zaheer Ahmed, MD

PC Shah, MD, Inc.

Pondville Medical Associates

Gloria Moussa-Gabour, MD

Pauline Yuen Chao, MD

David Siegenberg, MD, PC

Savitha Gowda, MD, PC

North Sububran Internal Medicine & Gastroenterological Associates

Esmail Fallah-Sohy, MD

Pulmonary & Primary Care Associates of Plymouth

Clara A Lennox MD

Hallmark Health Medical Associates

Robert F. Commito MD PC

DAF Medical Associates

Woburn Nephrology Associates

Main Street Family Practice

Rheumatology and Internal Medicine Associates

Reading Family Medicine

Billerica Family Physicians

Dutton Family Care Associates

Rebecca Spoerri-Bowman MD 

Ronald Sen, MD

Stephen P. Murphy, MD

Nicole Bloor, MD

Woodland Internists

Mandy Kaur, MD

John F. Yee, MD


ACO Particpants in Joint Ventures between ACO Professionals and Hospitals

  • None

ACO Governing Body

NEQCA Accountable Care, Inc is governed by a Board of Trustees including the following members:

  • Ahmed Basheer, MD, Voting Member and Chair, Ahmed Basheer, MD, PC
  • Deborah Blazey-Martin, MD, Voting Member, Pratt Medical Group, Inc
  • Matthew Larkin, Voting Member, Pratt Medical Group, Inc
  • Mark Singh, MD, Voting Member, Blue Hills Medical Associates
  • Dhiren Sutaria, MD, Voting Member, Woodland Internists 
  • Mark Collins, MD, Voting Member, Mark E. Collins, MD.
  • Andrew Romanowsky, MD, Voting Member, Mark Romanowsky, MD, PC
  • Meg Costello, Voting Member, Executive Director, NEQCA Accountable Care, Inc
  • Ronald W. Keating, Voting Member, Medicare Beneficiary Representative 
  • Nathan Gagne, Non-voting Member, Treasurer and CFO, NEQCA Accountable Care, Inc
  • Zachary Redmond, Non-voting Member, Secretary, NEQCA Accountable Care, Inc

Key ACO Clincal and Administrative Leadership

  • ACO Executive: Meg Costello
  • ACO Medical Director: Jatin Dave, MD
  • Compliance Officer: Cara Merski 

Associated Committees and Committee Leadership

  • Quality Committee, Chair: Jatin Dave, MD, ACO Medical Director
  • Funds Flow Committee, Chair: Mark Singh, MD, Blue Hills Medical Associates
  • Finance and Audit Committee, Chair: Matthew Larkin, Pratt Medical Group, Inc.

Types of ACO Participants, or Combinations of Participants, that Formed the ACO

  • Network of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

Agreement period beginning 2015, Performance Year 2015: $3,756,134

Shared Savings Distribution

Agreement period beginning 2015, Performance Year 2015
  • Proportion invested in infrastructure: 14%
  • Proportion invested in redesigned care process/resources: 61%
  • Proportion of distribution to ACO participants: 25%

Payment Rule Waivers

No, our ACO does not utilize the SNF 3-Day Rule Waiver

2015 Quality Performance Results 

2015 Reporting Period

Measure Number

Measure Name

NEQCA ACO Performance Rate

Mean Performance Rate (Shared Savings Program-ACOs)

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

79.89

80.61

ACO-2

CAHPS: How Well Your Providers Communicate

93.90

92.65

ACO-3

CAHPS: Patients’ Rating of Provider

92.80

91.94

ACO-4

CAHPS: Access to Specialists

86.77

83.61

ACO-5

CAHPS: Health Promotion and Education

62.42

59.06

ACO-6

CAHPS: Shared Decision Making

76.72

75.17

ACO-7

CAHPS: Health Status/Functional Status

74.57

72.30

ACO-34

CAHPS: Stewardship of Patient Resources*

23.41

26.87

ACO-8

Risk Standardized, All Condition Readmission

16.44

14.86

ACO-35

Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)* Readmission

19.68

18.07

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes*

57.15

54.60

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure*

88.49

76.96

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

69.67

62.92

ACO-9

Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI)#5)

1.36

1.11

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator(PQI)#8)

1.38

1.04

ACO-11

Percent of Primary Care Physicians who Successfully Meet Meaningful Use Requirements

94.44

80.14

ACO-39

Documentation of Current Medications in the Medical Record*

83.08

84.07

ACO-13

Falls: Screening for Future Fall Risk

77.18

56.46

ACO-14

Preventive Care and Screening: Influenza Immunization

63.70

62.03

ACO-15

Pneumonia Vaccination Status for Older Adults

61.07

63.73

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up

73.9

71.15

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

91.95

90.16

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

44.73

45.25

ACO-19

Colorectal Cancer Screening

62.50

60.06

ACO-20

Breast Cancer Screening

71.23

65.67

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

81.93

70.04

ACO-40

Depression Remission at Twelve Months*

N/A

N/A

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

12.37

20.38

ACO-41

Diabetes: Eye Exam*

35.74

41.05

ACO-28

Hypertension: Controlling High Blood Pressure

72.7

69.62

ACO-30

Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic

82.97

83.82

ACO-31

Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

82.31

87.22

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

64.58

77.73

CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.

*  = Measure required beginning Reporting Year 2015

N/A = Reporting on the depression remission measure is not required for 2015, as indicated by N/A




































































































































  • See 2012-2014 Quality Performance Results Table here

2015 Performance Summary Statistics

Performance Measure

ACO Performance Rate

Mean Performance Rate for All ACOs

Risk Standardized, All Condition Readmissions (ACO-8)

ASC Admissions: COPD or Asthma in Older Adults (ACO-9)

ASC Admission: Heart Failure (ACO-10)

Percent of Primary Care Providers who Qualified for EHR Incentive Payment (ACO- 11)